Fatty acid desaturation pathway regulation of VLC ceramide production

Exploratory Score: 0.800 Price: $0.50 inflammation IL-10 signaling-deficient cells Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting N/A in IL-10 signaling-deficient cells. Primary outcome: VLC ceramide levels and inflammatory response

Description

Investigation of the metabolic mechanism by which IL-10 controls VLC ceramide accumulation. The study examined how IL-10 signaling regulates metabolic flux through the de novo mono-unsaturated fatty acid synthesis pathway and its impact on saturated VLC ceramide production. Researchers tested whether restoring mono-unsaturated fatty acid availability to IL-10 signaling-deficient cells could limit saturated VLC ceramide production and associated inflammation.

TARGET GENE
N/A
MODEL SYSTEM
IL-10 signaling-deficient cells
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
de novo mono-unsaturated fatty acid synthesis, sphingolipid metabolism
SOURCE
extracted_from_pmid_38383790
PRIMARY OUTCOME
VLC ceramide levels and inflammatory response

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.800 composite

📖 Wiki Pages

Researchersindex

Protocol

Analysis of fatty acid synthesis pathway flux, measurement of mono-unsaturated fatty acid levels, assessment of VLC ceramide production, and evaluation of inflammatory markers

Expected Outcomes

Restoring mono-unsaturated fatty acid availability reduces VLC ceramide production and inflammation

Success Criteria

Demonstration that fatty acid availability controls VLC ceramide levels and inflammatory responses

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.